🇺🇸 FDA
Patent

US 8986688

WAP domain fusion polypeptides and methods of use thereof

granted A61KA61K38/00A61P

Quick answer

US patent 8986688 (WAP domain fusion polypeptides and methods of use thereof) held by Inhibrx, Inc. expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inhibrx, Inc.
Grant date
Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/00, A61P, A61P29/00, A61P31/00